MESENCHYMAL CHONDROSARCOMA
Clinical trials for MESENCHYMAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for MESENCHYMAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone cancer: targeted drug shows promise
Disease control OngoingThis study tested a drug called vismodegib in 45 people with advanced chondrosarcoma, a rare bone cancer that has spread and is hard to treat. The goal was to see if the drug could shrink tumors or stop them from growing for at least 6 months. Researchers measured how many patien…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
New combo therapy aims to shrink sarcomas before surgery
Disease control OngoingThis study looks at whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before they are removed surgically. About 140 adults and children with newly diagnosed, high-risk sarcomas that can be operated on are participating. Th…
Matched conditions: MESENCHYMAL CHONDROSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC